BellRing Brands reported first quarter earnings of $0.37 per share, exceeding the Zacks Consensus Estimate of $0.31 and marking a year-over-year decline from $0.58 in Q1 2025. Net sales reached $537.3 million, up 1% from the prior year, driven by a 0.7% volume increase and modest price/mix improvements. Operating profit was $78.5 million, and adjusted EBITDA stood at $90.3 million. Management highlighted headwinds from higher whey protein costs and increased promotional frequency, but anticipates second-half acceleration through stepped-up brand investment, innovation launches and expanded merchandising initiatives.

BellRing narrowed its full-year net sales guidance to a range of $2.41 billion to $2.46 billion, representing 4% to 6% growth, and set adjusted EBITDA expectations at $425 million to $440 million, or approximately 18% of net sales. Capital expenditures are projected at $8 million. The revision reflects input-cost inflation and heightened promotional activity, while management remains confident in achieving year-end objectives through targeted consumer demand initiatives and channel optimization.

Shareholder rights firm Hagens Berman has notified investors of a proposed class action accusing BellRing and certain executives of misrepresenting the drivers of 2025 sales growth. The complaint alleges that reported gains were fueled by retailer inventory hoarding rather than end-consumer demand, leading to a 33% single-day share collapse once excess stock was destocked in August 2025. Plaintiffs seek recovery for losses tied to an alleged $2.9 billion erosion in market capitalization. The lead plaintiff deadline is March 23, 2026, and the firm is urging affected investors to come forward promptly.